METiS Wins BIOCHINA Awards “2024 Innovative Breakthrough Enterprise” Prize_News_METiS TechBio

EN

Home

About us

Platforms

Pipeline

Partners

News

Investors

Information Release

Listing Documents

Announcements & Notices

Company Management

Financial Reports

Investor Calendar

Contact IR & Email Alert

Careers

Contact us
Home News News
METiS Wins BIOCHINA Awards “2024 Innovative Breakthrough Enterprise” Prize
2025.04.01

Recently, BIOCHINA 2025 was grandly held from March 13 to 15 at the Suzhou International Expo Center, during which the award ceremony of the “BIOCHINA Awards 2024 – 9th PharmCube Annual Biotech Industry Awards” also took place. With its outstanding technological innovation, METiS Therapeutics was awarded the BIOCHINA Awards “2024 Innovative Breakthrough Enterprise” prize.

METiS Wins BIOCHINA Awards “2024 Innovative Breakthrough Enterprise” Prize(图1)

Recommended News
METiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026
METiS TechBio to Present Late-Breaking Data on Near-Complete Cardiomyocyte Delivery at CRS 2026
2026.05.20
News
METiS TechBio and Grit Biotechnology Announce Immune-Targeted LNP Technology Collaboration; NanoForge Platform OpenCGT Collaborations Surpass RMB 6 Billion in Total Value
METiS TechBio and Grit Biotechnology Announce Immune-Targeted LNP Technology Collaboration; NanoForge Platform OpenCGT Collaborations Surpass RMB 6 Billion in Total Value
2026.05.18
News
Breakthrough Progress: METiS TechBio Publishes Consecutive Research Findings in Nature Communications and the Journal for ImmunoTherapy of Cancer
Breakthrough Progress: METiS TechBio Publishes Consecutive Research Findings in Nature Communications and the Journal for ImmunoTherapy of Cancer
2025.12.16
News
METiS BioTech announces China’s First AI-Enabled Formulation Drug Candidate to Complete Phase III Clinical Trial
METiS BioTech announces China’s First AI-Enabled Formulation Drug Candidate to Complete Phase III Clinical Trial
2025.10.23
News
METiS Launches World’s First AI-Driven Nano-Delivery Platform NanoForge
METiS Launches World’s First AI-Driven Nano-Delivery Platform NanoForge
2025.09.16
News
METiS Selected as MIT Technology Review's 50 Smartest Companies (TR50)
METiS Selected as MIT Technology Review's 50 Smartest Companies (TR50)
2025.09.13
News
METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing’s Biopharmaceutical Innovation Engine
METiS Technologies Closes RMB 400 Million Series D Financing to Power Beijing’s Biopharmaceutical Innovation Engine
2025.08.01
News
METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting
METiS Technologies Showcases AI-Powered Nanodelivery Platform at the 2025 Controlled Release Society Annual Meeting
2025.07.22
News
METiS Pharmaceuticals Announces Formation of Scientific Advisory Board Comprising World-Renowned Experts
METiS Pharmaceuticals Announces Formation of Scientific Advisory Board Comprising World-Renowned Experts
2025.04.25
News
This website uses cookies.
This website uses cookies to improve your experience when visiting this website. However, if you do not agree, you can also choose to cancel.
For more information, please refer to our Privacy Policy.